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The synthesis of six novel cyclometallated platinum(IV) compounds (3a-3c and 4a-4c) 
derived from ligand (4-FC6H4)CH=N(CH2)3N(CH3)2 (L) was achieved by intermolecular 
oxidative addition of halogens to cyclometallated platinum(II) compounds 
[Pt(CH3){(CH3)2N(CH2)3N=CH(4-FC6H3)}] (1) and [PtX{(CH3)2N(CH2)3N=CH(4-
FC6H3)}]  (2a, X = Cl; 2b, X = Br; 2c, X = I). While compound 2b could be obtained 
from 2a through Cl for Br substitution reaction, 2c was best obtained through 
cyclometallation of ligand L with [PtI2(dmso)2]. The X-ray molecular structures of 
[C,N,N’] platinum(II) (2b) and platinum(IV) (3b and 4b) cyclometallated  compounds 
and of the [N,N’] platinum (II) compound Ib, all of them containing bromido ligands, are 
reported. The absorption and emission spectra were also studied in dichloromethane 
solution at room temperature. All compounds, except 3c and 4c arising from oxidative 
addition of iodine, display a broad emission band in the 340-360 nm range, attributed to 
platinum disturbed intraligand (IL) transitions, when excited at the highest energy band, 




A large number of materials that can be applied as phosphorescent emitters in organic 
light-emitting diodes (OLEDs) are coordination compounds of the heavy late transition 
metals and many of them are cyclometallated complexes. A key to minimize non-
radiative decay is to use strong field ligands so that metal centered d-d states are not 
energetically accessible at room temperature. Aromatic cyclometallating ligands are 
attractive since in addition to strong ligand-field, these ligands produce generally rigid 
five-membered rings. Since rigidity generally favors luminescence over non-radiative 
decay pathways, tridentate ligands offer an advantage over bidentate ligands. In 
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particular, many cyclometallated platinum complexes are luminescent in solution and 
those containing tridentate [C,N,N] or [N,C,N] monoanionic ligands attract a great deal 
of interest as phosphorescent materials. The ancillary ligands completing the coordination 
of platinum and the substituents on the aryl ring are also crucial in the emission 
properties.1-4 In addition, many cyclometallated platinum compounds display anticancer 
activity and are attractive to be used as bioimaging agents.5-7 
In spite of the great number of planar cyclometallated platinum(II) compounds for which 
the luminescence properties have been reported, cyclometallated platinum(IV) 
compounds have received less attention.8-10  
In a previous study, we have analysed the synthetic method and the luminescence 
properties of platinum(II) cyclometallated compounds containing a tridentate [C,N,N’] 
imine ligand with fluoro substituents.11 In this work, we report the synthesis and 
luminescence properties of cyclometallated platinum(II) and platinum(IV) compounds 
containing a tridentate [C,N,N’] imine ligand with a para-fluoro substituent and methyl 
or halido (chlorido, bromido or iodido) ligands. The effect of the nature of the ancillary 
ligand and of the oxidation state of the platinum atom on the emission properties of these 
compounds will be analysed. 
 
RESULTS AND DISCUSSION 
Synthesis and characterization of the compounds 
Ligand (4-FC6H4)CH=N(CH2)3N(CH3)2 (L) was selected for this study since, according 
to previous results,11 this ligand allows formation of luminescent tridentate [C,N,N’] 
platinum(II) compounds and the presence of a fluoro substituent in para leads to higher 
quantum yields. In this work, cyclometallated platinum(II) compounds derived from 
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ligand L and containing CH3, Cl, Br or I as ancillary ligand will be prepared and halogen 
oxidative addition to these compounds will yield the corresponding cyclometallated 
platinum(IV) compounds. 
The synthesis of compounds 1 and 2a, depicted in scheme 1, has been previously reported 
from ligand L and using as metallating agents dimer [Pt2(CH3)4(-S(CH3)2)2] (D) or 
compound cis-[PtCl2(dmso)2] (A). The synthesis of new cyclometallated platinum(II) 
compounds [PtBr{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (2b) and 
[PtI{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (2c)  was attempted following the same method 
than for compound 2a using analogous cis-[PtX2(dmso)2] precursors (B, X = Br or C, X 
= I). This type of cyclometallation reactions can be carried out as one-pot procedure from 
the metallating agent and the ligand which are refluxed for several hours in a donor 
solvent in the presence of sodium acetate. Alternatively, the corresponding [N,N’]-chelate 
complex can be isolated and such complexes further react to yield cycloplatinated 
derivatives via C-H activation (see scheme 1).11-14 These reactions generally require 
prolonged reaction times and give moderate yields. In the present study, compound 
[PtI{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (2c) was best obtained using the one-pot 
procedure. In contrast, the bromo derivative [PtBr{(CH3)2N(CH2)3N=CH(4-FC6H3)}] 
(2b) could not be obtained in a pure form neither using the one-pot procedure nor with 
prior isolation of the [N,N’]-chelate complex Ib, since the obtained compound was 
impurified with small amounts of Ib. In view of these results, the synthesis of compound 
2b was carried out from compound [PtCl{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (2a) which 
was treated with an excess of KBr in refluxing methanol so that chlorido for bromido 








Scheme 1. Synthesis of cyclometallated platinum(II) compounds. (1): toluene, reflux 1h; (2): + 
sodium acetate, methanol, reflux, 72 h; (3) methanol, reflux, 4h; (4): + KBr, methanol, reflux, 48 




Compounds Ib, Ic, 2b and 2c were characterised by 1H and 19F NMR, mass spectra and 
elemental analyses which were consistent with the structures depicted in Scheme 1. For 
both compounds Ib and Ic containing a chelate [N,N’] ligands, the imine proton is 
coupled to platinum and the value of the coupling (3J(Pt-H) = 115.6 Hz) indicates that the 
imine adopts the E configuration in which the imine proton is trans to the platinum 
atom.11 This configuration is the most favoured for achieving the intramolecular C-H 
bond activation since it brings the aryl ligand close to the halido ligand. For compounds 
2b and 2c, the 1H NMR spectra confirm the formation of the expected fused [6,5,6]-
tricyclic systems. As reported for analogous systems,12-13, 15-16 3J(Pt-H) values (143.7 and 
135.8 Hz) for the imine proton are higher than those obtained for compounds I. The 
proton adjacent to the metallated carbon (Ha) is also coupled to platinum and the 3J(Pt-H) 
values are in the range expected (ca. 40 Hz). It is interesting to point out that the chemical 
shift of Ha depends on the nature of the halido group cis to the aryl and, as shown in figure 
S1, moves downfield following the sequence Cl (7.72 ppm) < Br (8.00 ppm) < I (8.45 
ppm). Although a decrease in the chemical shift of a nucleus with increasing atomic 
number of the vicinal halogen is frequently observed, inverse halogen dependence is also 
occasionally seen, and it has been suggested that the chemical shifts could be affected by 
spin-orbit coupling.17 
Compounds Ib and 2b were also characterised by single crystal X ray diffraction and the 
structures are shown in figures 1 and 2. Two (Ib) and three (2b) independent molecules 
with bond parameters equal within experimental error [3] are present in the asymmetric 
unit (see figures S2 and S3). In both cases, the platinum adopts a square-planar 
coordination. For Ib, the ligand adopts a bidentate [N,N’] coordination and the 
coordination is completed with two mutually cis bromido ligands. As observed in the 1H 
NMR spectra, the ligand adopts an E configuration around the imine moiety, so that the 
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phenyl ring is close to the platinum. As for 2b, the square-planar coordination of the 
platinum is completed with a tridentate [C,N,N’] ligand and a bromido ligand trans to the 
imine. As a result, a fused [6,5,6]-tricyclic system containing an ortho-metalated phenyl 
group, a five-membered platinacycle and a six-membered chelate ring with two nitrogen 
atoms coordinated to platinum is formed. 
Bond lengths and angles are well within the range of values obtained for analogous 
compounds.11-13 No significant differences are observed for Pt-Br distances which lie in 
the range 2.4238-2.4302 Å. In both compounds, the Pt-amine distances are greater than 
Pt-imine distances in agreement with the weaker ligating ability of amines for platinum, 
and Pt-amine distance is higher (2.197 Å) for 2b than for Ib (2.093 Å) in agreement with 
the greater trans influence of the aryl versus the bromido ligand. Most angles at platinum 
are close to the ideal value of 90º, and the smallest angle corresponds to the chelate angle 
N(1)-Pt-N(2) for Ib (89.27(10)º) or to the metallacycle C(1)-Pt-N(1) for 2b (80.8(3)º). 
For the latter, as previously observed for analogous cyclometallated compounds11,12 and 
in agreement with the flexibility of the ligands derived from propylenediamine, the 




Figure 1. Molecular structure of compound Ib (molecule a). Selected bond lengths (Å) and angles 
(deg.) with estimated standard deviations: Pt(1a)-N(1a): 2.016(2); Pt(1a)-N(2a): 2.093(2); Pt(1a)-
Br(1a): 2.4248(3); Pt(1a)-Br(2a): 2.4238(3); N(1a)-Pt(1a)-N(2a): 89.27(10); N(1a)-Pt(1a)-Br(1a): 
88.96(7); N(2a)-Pt(1a)-Br(2a): 92.36(7); Br(1a)-Pt(1a)-Br(2a): 89.361(11). 
 
 
Figure 2. Molecular structure of compound 2b (molecule a). Selected bond lengths (Å) and angles 
(deg.) with estimated standard deviations: Pt(1a)-C(1a): 1.993(9); Pt(1a)-N(1a): 2.019(7); Pt(1a)-
N(2a): 2.197(8); Pt(1a)-Br(1a): 2.4302(10); C(1a)-Pt(1a)-N(1a): 80.8(3); N(1a)-Pt(1a)-N(2a): 
95.8(3); C(1a)-Pt(1a)-Br(1a): 92.7(3); N(2a)-Pt(1a)-Br(1a): 90.5(2). 
 
 
Cyclometallated platinum(IV) compounds [Pt(CH3)X2{(CH3)2N(CH2)3N=CH(4-
FC6H3)}] (3a, 3b, 3c) were synthesized by oxidative addition of Cl2 (3a), Br2 (3b) or I2 
(3c) to cyclometallated platinum(II) compound 1 in acetone at room temperature (Scheme 
2). According to previously reported procedures,18-19 iodobenzene dichloride was used in 
the synthesis of 3a to avoid the handling of Cl2 gas. The proposed mechanisms for 
halogen oxidative addition reactions point to the formation of octahedral platinum(IV) 
compounds in which the new ligands are mutually trans as depicted in scheme 2.18-21 
Nevertheless, further isomerisation reactions might bring these ligands to mutually cis 
positions. In this study, 1H NMR spectra carried out for compounds 3 indicated the 
presence of only one isomer in each case. The obtained data (discussed below) are 
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consistent with the fact that the two halido ligands are mutually trans for 3b and 3c and 
mutually cis for 3a.  The isomerisation of compound 3a could arise from exchange of the 
positions of the chlorido and the methyl ligands, although taking into account the low 
lability of Pt-C bonds, a mer to fac-[C,N,N’] isomerisation of the tridentate ligand, as 
described for analogous cyclometallated platinum(IV) compounds, with exchange of the 
dimethylamino moiety and the chlorido ligand is also possible.14,22,23 These processes are 
depicted in scheme 3, and we might assume that they do not take place for 3b and 3c 
since a higher stability is obtained if the more bulky bromido or iodido ligands remain in 




Scheme 2. Synthesis of cyclometallated platinum(IV) compounds. (1): + PhICl2 (3a), + Br2 (3b), 
+ I2 (3c), acetone, r.t., 1 h; (2):  + PhICl2 (4a), + Br2 (4b), + I2 (4c), acetone, r.t., 1 h. The numbering 
scheme used for NMR is shown for the new compounds. 
 
Cyclometallated platinum(IV) compounds [PtX3{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (4a, 
X = Cl; 4b, X = Br; 4c, X = I) containing three halido ligands of the same nature were 
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synthesised following the same procedures used to prepare compounds 3 and were 




Scheme 3. Possible isomerization paths for compound 3a. (1): CH3/Cl exchange; (2): N(CH3)2/Cl 
exchange.  
 
Cyclometallated platinum(IV) compounds 3a-3c and 4a-4c were characterized by 1H and 
19F-NMR spectroscopy, MS-ESI+ and elemental analysis. For 3a, the platinum(IV) centre 
becomes chiral due to the trans-Cl2/ cis-Cl2 isomerization process indicated above and, 
therefore, the N(CH3)2 and the (CH2)3 protons are diastereotopic. All other compounds 
display simpler 1H NMR spectra in which the dimethylamino and the methylene protons 
are equivalent. Selected 1H NMR data for these compounds are collected in Table 1. In 
all cases, the imine proton is coupled to 195Pt and the 3J(Pt-H) values are in the range 44.6-
47.2 Hz for compounds 3 and 91.2-95.7 for compounds 4. These values are in agreement 
with the increased oxidation state of platinum and with the nature of the ligand in trans 
to the imine (CH3 for compounds 3 and halido for compounds 4). In most cases, 
3J(Pt-H) 
values were also observed for dimethylamino protons in the range 10.2-16.6 Hz and for 
the proton adjacent to the metalation site (Ha) in the range 33.3-38.2 Hz, thus confirming 
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the tridentate [C,N,N’] coordination of the imine ligand. In addition, for compounds 3, 
the methyl group is also coupled to platinum and the 2J(Pt-H) values (59.6-68.3 Hz) are 
reduced compared to those of the parent platinum(II) compound 1. The methyl resonance 
in compounds 3 is shifted downfield (3a, = 1.80; 3b, = 1.99; 3c, = 2.26) as the size 
of the halido ligand increases. As shown in figure S4, the size of the halido ligand affects 
the chemical shift of the imine proton which decreases for both series of compounds 3 
and 4 as the halido size increases. In addition, for compounds 4, the chemical shift of the 
proton adjacent to the metallation site(Ha) increases as the bulk of the halido ligand 
increases. 
 
Table 1.- Selected 1H NMR data for the studied compounds.a  
 
 (Hd) [3J(Pt-H)] (Ha) [3J(Pt-H)] (CH3) [
2J(Pt-H)] 
1b 8.66 [62.8] 7.21 [35.6] 0.81 [81.7] 
2a b 8.32 [141.6] 7.72 [40.0] - 
2b 8.33 [143.7] 8.00 [46.6] - 
2c 8.38 [135.8] 8.45 [39.8] - 
3a 8.49 [45.5] 7.01 [c] 1.80 [59.6] 
3b 8.37 [44.6] 7.02 [33.3] 1.99 [67.6] 
3c 8.21 [47.2] 7.02 [38.2] 2.26 [68.3] 
4a 8.19 [95.7] 7.78 [c] - 
4b 8.09 [93.9] 7.97 [c] - 
4c 7.96 [91.2] 8.25 [33.6] - 
 
a In CDCl3,  in ppm, J in Hz, labels as indicated in Schemes 1 and 2. 
b Values as previously 
reported.11  c Not observed. 
12 
 
Compounds 3b and 4b were also characterized by single crystal X ray diffraction and the 





Figure 3. Molecular structure of compound 3b. Selected bond lengths (Å) and angles (deg.) with 
estimated standard deviations: Pt(1)-C(1), 2.007(3); Pt(1)-C(13), 2.135(3); Pt(1)-N(1), 2.141(2); 
Pt(1)-N(2), 2.258(3); Pt(1)-Br(1), 2.4485(3); Pt(1)-Br(2), 2.4675(3); C(1)-Pt(1)-C(13), 94.51(11); 
C(1)-Pt(1)-N(1), 79.97(11); C(13)-Pt(1)-N(2), 90.27(10); N(1)-Pt(1)-N(2), 95.28(10); C(1)-
Pt(1)-Br(1), 86.43(8); C(13)-Pt(1)-Br(1), 91.27(8); N(1)-Pt(1)-Br(1), 89.37(7); N(2)-Pt(1)-Br(1), 




As expected from NMR studies, for both compounds, the platinum atom displays an 
octahedral coordination with a meridional tridentate [C,N,N’] ligand. An equatorial 
methyl and two bromido ligands (3b) or three bromido ligands (4b) complete the 
coordination around the platinum. Bond lengths and angles are well within the range of 
values obtained for analogous compounds.14 The main distortions from the ideal 
octahedral coordination correspond to the small bite angle of the metallacycles (3b, 
79.97(11)º and 4b, 80.3(3)º) and the large value of the [N,N’] chelate (3b, 95.28(10)º and 
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4b, 96.2(3)º). The axial ligand form a Br-Pt-Br angle of 173.947(11) (3b) or 173.99(3) 
(4b). As observed for 2b, the Pt-amine distances (3b, 2.258 and 4b, 2.276 Å) are greater 
than Pt-imine distances (3b, 2.141 and 4b, 2.032 Å) and the Pt-imine distance is longer 
for 3b (trans to a methyl ligand) than for 4b (trans to a bromido ligand) in agreement 
with the higher trans-influence of C-donor ligands. This is consistent with the lower 
coupling constant of the imine proton observed by 1H NMR spectroscopy for compound 
3b. A comparison of the bond distances of the cyclometallated platinum(IV) compounds 
with those of the platinum(II) precursor 2b reveals that the Pt-Nimine, Pt-Namine and Pt-C 





Figure 4. Molecular structure of compound 4b. Selected bond lengths (Å) and angles (deg.) with 
estimated standard deviations: Pt(1)-C(1), 2.027(9); Pt(1)-N(1), 2.032(8); Pt(1)-N(2), 2.276(8); 
Pt(1)-Br(1), 2.4496(10); Pt(1)-Br(3), 2.4624(9); Pt(1)-Br(2), 2.4636(10); C(1)-Pt(1)-N(1), 
80.3(3); N(1)-Pt(1)-N(2), 96.2(3); C(1)-Pt(1)-Br(1), 94.5(3); N(2)-Pt(1)-Br(1), 89.07(19); C(1)-
Pt(1)-Br(3), 89.8(2); N(1)-Pt(1)-Br(3), 88.1(2); N(2)-Pt(1)-Br(3), 91.9(2); Br(1)-Pt(1)-Br(3), 






Figures S5 and S6 show the packing arrangement for 3b and 4b, respectively. For 3b, 
intramolecular short contacts C-F···Br-Pt and C-F···H3CN are observed (d(F···Br) = 
3.176 Å and d(F···H) = 2.509 Å). In addition, bromido ligands display intramolecular 
interactions with aromatic and methyl protons (d(Br···H) = 2.959 Å and 3.115 Å, 
respectively). Analogous interactions of bromido ligands and aromatic and methylene 
protons are observed for 4b (d(Br···H) = 2.933 Å and 2.930 Å, respectively). For 4b, the 
fluoro substituent is not involved in intramolecular interactions while the axial bromido 
ligands lead to short contacts (d(Br···Br) = 3.674 Å). 
 
Absorption and emission spectroscopy 
Absorption and emission spectra of all the compounds were recorded in 10-4 M 
dichloromethane solutions at 298K. The results are summarized in Tables 2 and 3. 















285 (6548), 319  
(3158), 364 (3104), 
391 (2853) 
345 0.044a 
574, 619 0.001b 
2a 












288 (4524), 318 
(2713), 357 (2140), 
378 (2618) 
349 0.044a 
576, 622 xxxx 
Ic 




295 (4194), 325 
(2857), 386 (2731) 
356 0.045a 
 
a Quantum yields for emission in solution referred to naphthalene in cyclohexane. b Quantum 
yields for emission in solution referred to [Ru(bipy)3]Cl3 in H2O.  







298 K  
λmax/nm 
ɸa 
3a 274 (4929) 348 0.051 
3b 274 (8094) 351 0.064 
3c 
267 (24526), 360 
(1509) 
b c 
4a 287 (3831) 349 0.051 
4b 286 (6353) 350 0.056 
4c 
271 (23289), 379 
(3449), 450 (3286) 
b c 
 
a Quantum yields for emission in solution referred to naphthalene in cyclohexane. b Not observed. 




The absorption spectra of cyclometallated platinum(II) compounds show several bands 
in the UV-Visible range with moderate ɛ values (Figure S7). The lowest energy band in 
the range 357-391 nm with extinction coefficients between 2100 and 3100 M-1 cm-1 can 
be attributed to Pt(5d)→π*(L) metal-to-ligand charge transfer (MLCT) mixed with 
intraligand  transitions.11, 25-29 A higher energy absorption band is also observed in the 
285-300 nm range with higher ɛ values which is also recorded for the uncoordinated 
ligand L (Figure S8) and for this reason, it can be assigned to * intraligand transitions. 
Platinum(IV) complexes absorption spectra only show bands in the UV-Visible range 
between 267 and 290 nm. The metal loses electron density with the oxidation of platinum 
and the MLCT transitions previously observed in their analogous platinum(II) complexes 
disappear30  being the transition assigned as a intraligand charge transfer (ILCT) within 
the cyclometalated ligands.31 Only compounds 3c and 4c show additional absorption 
bands in the 360-450 nm range (Figure S9). According to the literature, due to the 
significant π-donating ability of the iodido ligand, the possible origin of this band is 
ligand-to-ligand charge transfer (LLCT, I-→π*(L)) or ligand-to-metal charge transfer 
(LMCT, I-→ dσ*(Pt)) transitions.9  
All compounds, except 3c and 4c, display a broad emission band in the 340-360 nm range 
when excited at the highest energy band (Figure 5 and figures S10-S12). This band 
matches the emission of the free ligand L, shown in figure S13, when excited at the same 
wavelength and therefore, this emission could be attributed to intraligand (1IL) transitions 
perturbed by the Pt center.29,32   
Higher emission intensity was found for ligand L with respect to its complexes. This may 
be due to the metal orbital contribution to the emitting excited state of the complexes, 




As previously observed,11  the platinum(II) compound with chlorido as an ancillary ligand 
(2a) displays the most intense emission, among the studied cyclometallated platinum(II) 
compounds.  
Coordination compounds Ib and Ic, in which the ligand act as [N,N’]-chelate, show a 
lower emission intensity when compared to the corresponding [C,N,N’] cyclometallated 
platinum(II) analogues 2b and 2c, respectively.  
Compounds 1, 2a and 2b display an additional well-resolved band centred at ca. 620 nm 
when excited at the lowest energy absorption band (Figure S14). The vibronic structure 
of the band with progressional spacings of 1200 cm-1, typical of ʋ(C=C) and ʋ(C=N) 
stretching frequencies in the excited state, demonstrates the involvement of ligand 
character in 
their emission origin. 
The large Stokes’ shift 
together with the quenching of the intensity of 








Figure 5: Excitation and emission spectra of compounds 2b (left) and 4b (right) in dichloromethane 
solution at 298 K. 
 


















































Higher emission intensity was recorded, in general, for platinum(IV) with corresponding 
higher emission quantum yields about 5%, as previously observed in other 
cyclometallated platinum complexes.34 Similar quantum yield value was also recorded 
for Pt(II) complex 2a, ascribed to the presence of a chlorido ancillary ligand according to 
previous data.11 On the contrary, no significant emission was displayed by iodine 
derivatives, probably due to iodido heavy atom quenching.35 
 
CONCLUSIONS 
The synthesis of [N,N’]-chelate (Ib and Ic), [C,N,N’]-cyclometallated platinum(II) (1, 
2a-2c) and [C,N,N’]-cyclometallated platinum(IV) compounds (3a-3c and 4a-4c) was 
achieved. All the compounds were fully characterised including X ray crystal structure 
determination of the compounds containing bromido ligands Ib, 2b, 3b and 4b. The 
analyses of these structures indicate than in all cases the molecules are held together by 
van der Waals interactions only. 
The electronic absorption and emission properties of these compounds were investigated. 
The cyclometallated platinum(II) compounds 1, 2a, 2b, and 2c are emissive in the 340-
360 nm range when excited at the highest energy band (285-295 nm) observed in the 
absorption spectra, and this emission can be attributed to intraligand transitions. Non-
cyclometallated platinum(II) compounds Ib and Ic are also emissive in this region 
although with a lower intensity. Compounds 1 and 2a also emit at about 620 nm when 
excited at the lowest energy absorption band (357-391 nm) attributed to Pt(5d)→ p*(L) 
MLCT transition.  
The platinum(IV) compounds 3a, 3b, 4a, and 4b arising from oxidative addition of 
chlorine or bromine are emissive in the 300-400 nm range when excited at the highest 
energy absorption band, but compounds 3c and 4c, arising from oxidative addition of 
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iodine are not emissive probably due to the presence of iodido ligands. In particular, for 
the compounds containing bromido ligands the intensity of the emission follows the trend 
Ib < 2b < 4b < 3b, which indicates that the emission is enhanced for cyclometallated 
versus non-cyclometallated compounds and for platinum(IV) versus platinum(II) 
compounds. The lower emission intensity observed for 4b, containing three bromido 
ligands, than for 3b, containing two bromido ligands, and the lack of emission of 
compounds 3c and 4c containing iodido ligands could be related with the heavy atom 
effect. As a whole, the results obtained in this work indicate that bromido ligands are a 
good choice to enhance the luminescence of cyclometallated platinum(IV) compounds 
and that tuning the nature and number of the halido ligands could be a good strategy to 





Microanalyses were performed at the Centres Científics i Tecnològics (Universitat de 
Barcelona) using a Carlo Erba model EA1108 elemental analyser. Electrospray mass 
spectra were performed at the Unitat d’Espectrometria de Masses (Universitat de 
Barcelona) in a LC/MSD-TOF spectrometer using H2O-CH3CN 1:1 to introduce the 
sample. NMR spectra were recorded in CDCl3 at the Unitat d’RMN of the Universitat de 
Barcelona with a Mercury 400 spectrometer (1H, 400 MHz; 19F, 376.5 MHz). Chemical 
shifts are given in δ values (ppm) relative to TMS (1H) or CFCl3 (
19F) and coupling 
constants J are given in Hz. Multiplicity is expressed as: s (singlet), d (doublet), t (triplet), 
q (quadruplet), qi (quintuplet)  and m (multiplet). Numbering schemes for the compounds 
characterized are displayed in Schemes 1 and 2. UV/Vis spectra were recorded in CH2Cl2 
with a Cary 100 scan 388 Varian UV spectrometer. Emission and excitation spectra were 
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recorded in a Horiba Jobin-Yvon SPEX Nanolog-TM spectrofluorimeter at 298 K using 
10-4M solutions. Total luminescence quantum yields were measured at 298K relative to 




Preparation of the complexes 
All reagents were obtained from commercial sources and used as received. Ligand 4-
FC6H4CHN(CH2)3N(CH3)2 (L)
11, reagent PhICl2








37 were prepared as reported elsewhere.  
[PtBr2{(CH3)2N(CH2)3N=CH(4-FC6H4)}] (Ib) was obtained from the reaction of 0.405 
g (0.797 mmols) of [PtBr2(dmso)2] (B) and 0.177 g (0.850 mmols) of L in 25 ml of dry 
methanol. The mixture was refluxed at 65 ᵒC for 4 hours. Half of the volume was removed 
under vacuum and the solution was left to crystallise in the freezer. The yellow solid was 
filtered and dried under vacuum. Yield: 0.25 g (56%).1H NMR (CDCl3, 400 MHz): δ 
9.38 [m, 2H, Ha]; 8.43 [s, 1H, 3J(Pt-H) = 115.6, Hd]; 7.27 [t, 2H, 3J(F-H) = 8.0, Hb]; {4.93 
[m, 1H]; 4.11 [m, 1H]; 3.49 [m, 1H]; 2.62 [m, 1H]; 2.17 [m, 1H]; 1.99 [m, 1H], He,f,g}; 
{2.95 [s, 3H]; 2.85 [s, 3H], Hh} 19F NMR (CDCl3, 376.5 MHz): δ -101.50 [m, 1F]. MS-
ESI+: m/z 483.02 [M-Br]+. Anal. Found (calcd for C12H17Br2FN2Pt): C, 26.27 (25.59); 
H, 3.23 (3.04); N, 5.01 (4.97). 
[PtI2{(CH3)2N(CH2)3N=CH(4-FC6H4)}] (Ic) was obtained from the reaction of 0.225 g 
(0.372 mmols) of [PtI2(dmso)2] (C) and 0.082 g (0.394 mmols) of L in 25 ml of dry 
methanol. A brown solid was obtained following the same procedure used for Ib. Yield: 
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0.10 g (41%).1H NMR (CDCl3, 400 MHz): δ 9.45 [m, 2H, H
a]; 8.47 [s, 1H, 3J(Pt-H) = 
115.6, Hd]; 7.25 [t, 2H, 3J(F-H) = 8.0, Hb]; {4.95 [m, 1H]; 4.13 [m, 1H]; 3.23 [m, 1H]; 
2.72 [m, 1H]; 2.50 [m, 1H]; 1.97 [m, 1H], He,f,g}; {2.97 [s, 3H]; 2.84 [s, 3H], Hh} 19F 
NMR (CDCl3, 376.5 MHz): δ -101.50 [m, 1F]. MS-ESI
+: m/z 530.00 [M-I]+. Anal. 
Found (calcd for C12H17I2FN2Pt): C, 21.56 (21.93); H, 2.67 (2.61); N, 4.07 (4.26). 
[PtBr{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (2b) was obtained from the reaction of 0.102 
g (0.233 mmols) of [PtCl{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (2a) and 0.116 g (0.975 
mmols) of KBr in 10 ml of dry methanol. The mixture was refluxed at 65 ᵒC for 48 hours 
and the solvent was removed under vacuum. The residue was extracted with 10 ml of 
CH2Cl2 and 10 ml of methanol were added. Half of the volume was removed under 
vacuum and the solution was left to crystallise in the freezer. The orange solid was filtered 
and dried under vacuum. Yield: 0.039 g (35%). 1H NMR (CDCl3, 400 MHz): δ 8.33 [t, 
1H, 4J(H-H) = 1.5, 3J(Pt-H) = 143.7, Hd]; 8.00 [dd, 1H, 3J(F-H) = 10.7, 4J(H-H) = 2.5, 
3J(Pt-H) = 46.6, Ha]; 7.26 [m, 1H, Hc]; 6.68 [td, 1H, 3J(F-H) = 3J(H-H) = 8.5, 4J(H-H) = 
2.5, Hb]; 3.86 [t, 2H, 3J(H-H) = 5.1, 3J(Pt-H) = 35.2, He]; 2.86 [m, 8H, Hg,h]; 2.03 [qi, 2H, 
3J(H-H) = 5.6, Hf]. 19F NMR (CDCl3, 376.5 MHz): δ -103.85 [m, 1F]. MS-ESI
+: m/z 
438.02 [M+H] +; 402.10 [M-Br] +. Anal. Found (calcd for C12H16BrFN2Pt): C, 30.00 
(29.89); H, 3.45 (3.34); N, 5.70 (5.81). 
[PtI{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (2c) was obtained from the reaction of 0.306 g 
(0.504 mmols) of cis-[PtI2(dmso)2] (C), 0.133 g (0.639 mmols) of 4-
FC6H4CH=N(CH2)3N(CH3)2 (L) and 0.053 g (0.646 mmols) of anhydrous sodium acetate 
in 50 ml of dry methanol. The mixture was refluxed at 65 ᵒC for 72 hours and the solvent 
was removed under vacuum. The residue was extracted with 10 ml of CH2Cl2 and 10 ml 
of methanol were added. Half of the volume was removed under vacuum and the solution 
was left to crystallise in the freezer. The red solid was filtered and dried under vacuum. 
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Yield: 0.081 g (30%). 1H NMR (CDCl3, 400 MHz): δ 8.45 [dd, 1H, 
3J(F-H) = 11.4, 4J(H-
H) = 2.5, 3J(Pt-H) = 39.8, Ha]; 8.38 [t, 1H, 4J(H-H) = 1.7, 3J(Pt-H) = 135.8, Hd]; 7.26 [m, 
1H, Hc]; 6.65 [td, 1H, 3J(F-H) = 3J(H-H) = 8.4, 4J(H-H) = 2.6, Hb]; 3.83 [t, 2H, 3J(H-H) = 
5.6, He]; 3.01 [s, 6H, 3J(Pt-H) =16.7, Hh]; 2.81 [m, 2H, Hg]; 2.05 [qi, 2H, 3J(H-H) = 5.7, 
Hf]. 19F NMR (CDCl3, 376.5 MHz): δ -103.71 [m, 1F]. MS-ESI
+: m/z 530.01 [M+H]+ ; 
443.12 [M-I+CH3CN]
+; 401.09 [M-I]+; 402.09 [M-I]+. Anal. Found (calcd for 
C12H16IFN2Pt): C, 27.08 (27.23); H, 3.13 (3.05); N, 5.23 (5.29). 
[Pt(CH3)Cl2{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (3a) was obtained from the reaction of 
0.076 g (0.182 mmols) of [Pt(CH3){(CH3)2N(CH2)3N=CH(4-FC6H3)}] (1) and 0.051 g 
(0.185 mmols) of iodobenzene dichloride in 8 ml of acetone. The mixture was stirred at 
room temperature for 1 hour and the solvent was removed under vacuum. The residue 
was treated with diethyl ether and the yellow solid was filtered and dried under vacuum. 
Yield: 0.071 g (80%). 1H NMR (CDCl3, 400 MHz): δ 8.49 [s, 1H, 
3J(Pt-H) = 45.5, Hd]; 
7.43 [dd, 1H, 3J(H-H) = 8.3, 3J(F-H) = 5.6, Hc]; 7.01 [dd, 1H, 3J(F-H) = 8.9, 4J(H-H) = 
2.4, Ha]; 6.83 [td, 1H, 3J(F-H) =  3J(H-H) = 8.4, 4J(H-H) = 2.4, Hb]; 4.26 [m, 1H, He]; 3.90 
[m, 1H, He];  2.94 [m, 2H, Hg]; 2.65 [s, 3H, Hh]; 2.48 [s, 3H, Hh]; 2.27 [m, 1H, Hf]; 2.12 
[m, 1H, Hf]; 1.80 [s, 3H, 2J(Pt-H) = 59.6, Hi]. 19F NMR (CDCl3, 376.5 MHz): δ -101.46 
[m, 1F]. MS-ESI+: m/z 494.11 [M-Cl+CH3CN]
+; 453.09 [M-Cl]+;  416.11 [M-2Cl-H]+. 
Anal. Found (calcd for C13H19Cl2FN2Pt·2H2O): C, 29.80 (29.78); H, 3.78 (4.42); N, 5.27 
(5.34).  
[Pt(CH3)Br2{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (3b) was prepared as an orange solid 
by following the same method from 0.078 g (0.187 mmols) of compound 1 and 0.060 g 
(0.375 mmols) of Br2. Yield: 0.082 g (76%). 
1H NMR (CDCl3, 400 MHz): δ 8.37 [s, 1H, 
3J(Pt-H) = 44.6, Hd]; 7.43 [dd, 1H, 3J(H-H) = 8.3, 3J(F-H) = 5.8, Hc]; 7.02 [dd, 1H, 3J(F-
H) = 9.9, 4J(H-H) = 2.3, 3J(Pt-H) = 33.3, Ha]; 6.76 [td, 1H, 3J(F-H) = 3J(H-H) = 8.5, 4J(H-
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H) = 2.4, Hb]; 4.01 [m, 2H, He]; 2.98 [m, 2H, Hg]; 2.87 [s, 6H, 3J(Pt-H) =  15.1, Hh]; 2.21 
[m, 2H, Hf]; 1.99 [s, 3H, 2J(Pt-H) = 67.6, Hi]. 19F NMR (CDCl3, 376.5 MHz): δ -102.43 
[m, 1F]. MS-ESI+: m/z 538.06 [M-Br+CH3CN]
+; 497.03 [M-Br]+; 416.11 [M-2Br-
H]+.Anal. Found (calcd for C13H19Br2FN2Pt·H2O): C, 25.69 (26.23); H, 3.20 (3.19); N, 
4.53 (4.71).  
[Pt(CH3)I2{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (3c) was prepared as a dark brown solid 
by following the same method from 0.073 g (0.175 mmols) of compound 1 and 0.055 g 
(0.217 mmols) of I2. Yield: 0.061 g (52%). 
1H NMR (CDCl3, 400 MHz): δ 8.21 [t, 1H, 
4J(H-H) = 1.7, 3J(Pt-H) = 47.2, Hd]; 7.45 [dd, 1H, 3J(H-H) = 8.3, 3J(F-H) = 5.7, Hc]; 7.02 
[dd, 1H, 3J(F-H) = 9.7, 4J(H-H) = 2.4, 3J(Pt-H) = 38.2, Ha]]; 6.64 [td, 1H, 3J(F-H) = 3J(H-
H) = 8.5, 4J(H-H) = 2.3, Hb]; 4.06 [t, 2H, 3J(H-H) = 4.6, He]; 3.18 [s, 6H, 3J(Pt-H) = 17.4, 
Hh]; 3.05 [m, 2H, Hg]; 2.26 [s, 3H, 2J(Pt-H) = 68.3, Hi], 2.22 [m, 2H, Hf]. 19F NMR 
(CDCl3, 376.5 MHz): δ -102.63 [m, 1F]. MS-ESI
+: m/z 688.96 [M+NH4]
+; 544.02 [M-
I]+; 415.11 [M-2I-H]+. Anal. Found (calcd for C13H19I2FN2Pt·½I2): C, 19.14 (19.56); H, 
2.16 (2.40); N, 3.17 (3.51).  
PtBr3{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (4b) was prepared as a brown solid by 
following the same method from 0.029 g (0.060 mmols) of 
[PtBr{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (2b) and 0.050 g (0.313 mmols) of Br2. Yield: 
0.039 g (86%). 1H NMR (CDCl3, 400 MHz): δ 8.09 [s, 1H, 
3J(Pt-H) = 93.9, Hd]; 7.97 
[dd, 1H, 3J(F-H) = 9.5, 4J(H-H) = 2.6, Ha]; 7.52 [dd, 1H, 3J(H-H) = 8.9, 4J(F-H) = 5.4, 
Hc]; 6.85 [td, 1H, 3J(F-H) = 3J(H-H) = 8.2, 4J(H-H) = 2.1, Hb]; 3.99 [t, 2H, 3J(H-H) = 5.1,  
He]; 3.17[s, 6H, 3J(Pt-H) = 13.4, Hh]; 2.94 [m, 2H, Hg]; 2.28 [m, 2H, Hf]. 19F NMR 
(CDCl3, 376.5 MHz): δ -101.75 [m, 1F]. MS-ESI
+: m/z 642.85 [M+H]+; 562.90 [M-Br]+; 
483.02 [M-2Br+H]+. Anal. Found (calcd for C12H16Br3FN2Pt): C, 22.38 (22.45); H, 2.65 
(2.51); N, 3.99 (4.36). 
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[PtI3{(CH3)2N(CH2)3N=CH(4-FC6H3)}] (4c) was prepared as a dark brown solid by 
following the same method from 0.035 g (0.058 mmols) of [PtI{(CH3)2N(CH2)3N=CH(4-
FC6H3)}] (2c) and 0.059 g (0.232 mmols) of I2. Yield: 0.043 g (93%). 
1H NMR (CDCl3, 
400 MHz): δ  8.25 [dd, 1H, 3J(Pt-H) = 33.6, 3J(F-H) = 10.3, 4J(H-H) = 2.4, Ha]; 7.96 [s, 
1H, 3J(Pt-H) = 91.2, Hd]; 7.52 [dd, 1H, 3J(H-H) = 8.2, 4J(F-H) = 5.9, Hc]; 6.66 [td, 1H, 
3J(F-H) = 3J(H-H) = 8.3, 4J(H-H) = 2.4, Hb]; 3.96 [t, 2H, 3J(H-H) = 5.6, He]; 3.55 [s, 6H, 
3J(Pt-H) = 16.6, Hh]; 2.92 [m, 2H, Hg]; 2.32 [qi, 2H, 3J(H-H) = 5.2, Hf]. 19F NMR (CDCl3, 
376.5 MHz): δ -97.45 [m, 1F]. MS-ESI+: m/z 783.82 [M+H]+, 655.90 [M-I]+, 529.00 [M-
2I-H]+. Anal. Found (calcd for C12H16I3FN2Pt·½I2): C, 15.44 (15.84); H, 1.87 (1.77); N, 
2.82 (3.08). 
X ray diffraction  
Suitable crystals of compounds Ib, 2b, 3b and 4b were grown at room temperature in 
dichloromethane-methanol. X-ray diffraction data were collected for prism-like 
specimens on a D8 VENTURE system equipped with a multilayer monochromator and a 
Mo high brilliance Incoatec Microfocus Source ( = 0.71073 Å) at 100 K (1b, 3b and 4b) 
or at 293 K (2b). The structures were solved and refined using the Bruker SHELXTL 
Software package.38 Crystallographic details are given in Table 4. 
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Table 4. Crystal data and structure refinement for Ib, 2b, 3b and 4b. 
 
Compound Ib 2b 3b 4b 
Formula C12H17Br2FN2Pt C12H16BrFN2Pt C13H19Br2FN2Pt C12H16Br3FN2Pt 
Crystal size, mm 0.065 x 0.154 x 0.213 0.305 x 0.103 x 0.054 0.252 x 0.127 x 0.076 0.306 x 0.174 x 0.072 
Fw 563.18 482.27 577.21 642.09 
Temp, K 100(2)  293(2)  100(2) 100(2) 
Wavelength, Å 0.71073 0.71073 0.71073 0.71073 
Crystal system triclinic monoclinic monoclinic orthorhombic 
Space group P-1 P21/c P21/c Pna21 
a, Å 10.7938(5) 15.4189(18) 8.0750(3) 15.9976(6) 
b, Å 11.4007(5) 8.7061(10) 8.1606(3) 7.1424(3) 
c, Å 13.4215(7) 30.311(3) 23.9013(9) 13.7123(5) 
, º 89.584(2) 90 90.0 90.0 
, º 75.569(2) 104.344(4) 98.3600(10) 90 
, º  71.945(2) 90 90.0 90.0 
Volume, Å3 1516.34 (13) 3942.1(8) 1720.06(12) 1566.78(11) 
Z 4 12 4 4 
Dcalc, mg/m
3 2.467 2.438 2.460 2.722 
abs. coef., mm-1 14.519 13.710 14.131 16.604 
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F(000) 1040 2688 1072 1176 
 range for data coll, º 2.560  to  30.562 2.440 to  30.628 2.549 to 30.539 2.546 to 30.533 
Reflns coll. / independent 88505 / 9284  95319 / 12130 50.737 / 4732 20770 / 4695 
Data /restraint /parameters 9284  / 0/ 329 12130 / 0/ 466 4732 / 2/ 175 4695/ 3/ 174 
GOF on F2 1.029 1.012 1.106 1.046 
Final R index (I>2(I)) R1 = 0.0212,  
wR2 = 0.0541 
R1 = 0.0604,  
wR2 = 0.0718 
R1 = 0.0197,  
wR2 = 0.0444 
R1 = 0.0300,  
wR2 = 0.0673 
R index (all data) R1 = 0.0242,  
wR2 = 0.0554 
R1 = 0.1368, 
wR2 = 0.0858 
R1 = 0.0235, 
wR2 = 0.0458 
R1 = 0.0376, 
wR2 = 0.0707 
Peak and hole, e Å-3 1.832 and -2.092 3.091 and -3.050 1.402 and -1.515 1.049 and -2.385 
CCDC numbers 1856035 1856038 1856037 1856036 
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Supporting Information Available 
 
Fig. S1 and S4 showing the aromatic region of the 1H NMR spectra, fig. S2-S3 showing 
the unit cell of compounds Ib and 2b, fig. S5 and S6 showing the packing of compounds 
3b and 4b, fig. S7-S9 showing the absorption spectra of the platinum compounds and the 
ligand, fig S10-S15 showing the emission spectra of the platinum compounds and the 
ligand. The crystallographic data of compounds Ib, 2b, 3b and 4b have been deposited 
with the Cambridge Crystallographic Data Centre, CCDC No. 1856035-1856038.  
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